MDxHealth SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by MDxHealth SA for the month of October 2023. The filing, dated October 10, 2023, serves to furnish a press release issued by the Company on October 9, 2023 (attached as Exhibit 99.1).
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a financial statement.
Material Changes
The filing text does not disclose specific material changes versus prior periods. The content is limited to the announcement of the attached press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, or specific risk factors. It explicitly states that the information in the attached press release is furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference except as expressly set forth.
Key Facts for Investor Verification
- The filing references a press release dated October 9, 2023, which is attached as Exhibit 99.1 but not included in the provided text.
- Michael McGarrity, Chief Executive Officer, signed the report on behalf of the registrant.
- The Company is headquartered in Herstal, Belgium.
- Investors must review the attached Exhibit 99.1 directly to obtain the details of the announcement, as the Form 6-K text itself contains no operational or financial data.